Progress in treatment of later period non-small cell lung cancer / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 142-143, 2007.
Article
ي Zh
| WPRIM
| ID: wpr-383991
المكتبة المسؤولة:
WPRO
ABSTRACT
The lung cancer outbreak takes the first place in the global malignant tumor outbreak,becoming mainly reason to make death.Non-small cell lung cancer accounts for 80% of lung cancer around,70%~80% has already belonged to a later period while diagnosing(Ⅲ~Ⅳ period),It is the recommendation mode for later period NSCLC that the chemotherapy and radio treatment to put.The solution of using DDP/CBP with taxanens/gemcitabine/vinorelbine can raise curative effect further.It is a new way to treat later period NSCLC that is to use targeted treatment drug.
النص الكامل:
1
الفهرس:
WPRIM
نوع الدراسة:
Guideline
اللغة:
Zh
مجلة:
Cancer Research and Clinic
السنة:
2007
نوع:
Article